The World Health Organization said on May 23 that it expects to identify more cases of monkeypox as it expands surveillance in countries where the disease is not typically found. As of Saturday, 92 confirmed cases and 28 suspected cases of monkeypox have been reported from 12 member states that are not endemic for the virus, the U.N. agency said.
Monkeypox virus (MPXV) is a zoonotic virus in the family Poxviridae, genus Orthopoxvirus. It was first isolated from lesions seen among captive monkeys in Copenhagen, Denmark.Human monkeypox was subsequently identified in 1970 in the Democratic Republic of the Congo (DRC). ” Recently the U.N. agency reported that human-to-human transmission is occurring among people in close physical contact with cases who are symptomatic.
In light of the recent monkeypox virus transmissions, early detection of the virus is crucial for both natural outbreaks and potential acts of bioterrorism. Relying on its international leading diagnostic technology platform and experience in COVID-19 and various emerging infectious pathogens, Testsea was soon aware of the need for rapid and accurate diagnostics to detect these emerging viral pathogens.
Since the beginning of the COVID-19 outbreak, Testsea, as one of the global leaders in medical device innovation, has been at the forefront of this battle. Testsea is always willing to go to provide the essential solutions support to the world most quickly and efficiently during the crucial time of infectious disease, even under tremendous risks and uncertainty.
Because of the R & D team sustaining efforts, Testsea has successfully developed the detection kit for monkeypox virus DNA(PCR-Fluorescence Probing), which can quickly identify monkeypox virus by specifically testing the nucleic acid fragment of monkeypox virus. The reagent has the characteristics of high sensitivity and simple operation. Currently the company is actively promoting the registration of CE certification and we’re expected to receive it recently.
Post time: May-24-2022